PhRMA drums out 22 members who didn’t make the cut as major league R&D players
The shakeout at PhRMA is over.
After being swept up into the controversy that surrounded a couple of its top members with a notoriously …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
